Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of PRO-167 Ophthalmic Gel in Healthy Subjects
NCT03520348Phase 1Completed
- Sponsor
- Laboratorios Sophia
- Start
- Oct 2017
- Primary completion
- May 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of dexpanthenol in dry eye syndrome (DED) (2 arms), sponsored by Laboratorios Sophia. Primary endpoint: Goblet Cell Density at Day 11. Started Oct 2017; status: completed.
02
Drugs
dexpanthenol
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT03520348.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03520348.